The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BioMarin Pharmaceutical Inc(NASDAQ:BMRN) 
BioMarin Pharmaceutical Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Aldurazyme to treat mucopolysaccharidosis I, a genetic disease; Brineura for the treatment o...
Website: http://www.biomarin.com
Founded: 1997
Full Time Employees: 3,001
Sector: Healthcare
Industry: Biotechnology
BioMarin Pharmaceutical Days Payable Outstanding ttm (DPO)
BioMarin Pharmaceutical Days Receivable Outstanding ttm (DSO)
BioMarin Pharmaceutical Days Inventory Outstanding ttm (DIO)
BioMarin Pharmaceutical Op Cashflow Per Share ttm
BioMarin Pharmaceutical Free Cashflow Per Share ttm
BioMarin Pharmaceutical Cash Per Share ttm
BioMarin Pharmaceutical P/S ratio ttm
BioMarin Pharmaceutical (GAAP) P/E ratio ttm
BioMarin Pharmaceutical P/B ratio ttm
No extra charts and metrics for this ticker.